![Karl Schweitzer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karl Schweitzer
Presidente presso Biomodex SAS
Profilo
Karl Schweitzer is currently the Chairman at Biomodex SAS since 2020.
Prior to this, he was the President & Chief Executive Officer at Transform Cosmetic Surgery Group Ltd.
He also served as the Chairman at EBS Technologies GmbH from 2013 to 2017.
Additionally, he was the President-International at Autonomic Technologies, Inc. Dr. Schweitzer holds an MBA from INSEAD, a graduate degree from Vienna University of Economics & Business, and a doctorate from the University of Vienna.
Posizioni attive di Karl Schweitzer
Società | Posizione | Inizio |
---|---|---|
Biomodex SAS
![]() Biomodex SAS Commercial Printing/FormsCommercial Services Biomodex SAS develops 3D printed surgical simulators for medical education and patient-specific preoperative planning. It offers simulators for surgical procedures such as bone drilling, soft tissue suturing, medical device implantation, and sizing. The company was founded by Thomas Marchand and Sidarth Radjou on January 22, 2015 and is headquartered in Paris, France. | Presidente | 02/06/2020 |
Precedenti posizioni note di Karl Schweitzer
Società | Posizione | Fine |
---|---|---|
Transform Cosmetic Surgery Group Ltd.
![]() Transform Cosmetic Surgery Group Ltd. Hospital/Nursing ManagementHealth Services Transform Cosmetic Surgery Group Ltd. provides cosmetic surgery services. Its services include breast, fat reduction & tummy tuck surgery, cosmetic dentistry, anti-wrinkle, hair loss and hair removal treatments. The company is headquartered in Manchester, UK | Amministratore Delegato | - |
Autonomic Technologies, Inc.
![]() Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Corporate Officer/Principal | - |
EBS Technologies GmbH
![]() EBS Technologies GmbH Electronic Equipment/InstrumentsElectronic Technology EBS Technologies GmbH develops medical devices and therapeutic applications for the treatment of neurological disorders. The firm develops a NEXT WAVE prototype device for non-invasive electrical stimulation that is currently used for clinical trials. The company was founded by Bernhard Sabel, Anton Yurevich Fedorov and Kornelia Sabel in 2007 and is headquartered in Hennigsdorf, Germany. | Amministratore Delegato | - |
Formazione di Karl Schweitzer
INSEAD | Masters Business Admin |
Vienna University of Economics & Business | Graduate Degree |
University of Vienna | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Autonomic Technologies, Inc.
![]() Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Technology |
Transform Cosmetic Surgery Group Ltd.
![]() Transform Cosmetic Surgery Group Ltd. Hospital/Nursing ManagementHealth Services Transform Cosmetic Surgery Group Ltd. provides cosmetic surgery services. Its services include breast, fat reduction & tummy tuck surgery, cosmetic dentistry, anti-wrinkle, hair loss and hair removal treatments. The company is headquartered in Manchester, UK | Health Services |
EBS Technologies GmbH
![]() EBS Technologies GmbH Electronic Equipment/InstrumentsElectronic Technology EBS Technologies GmbH develops medical devices and therapeutic applications for the treatment of neurological disorders. The firm develops a NEXT WAVE prototype device for non-invasive electrical stimulation that is currently used for clinical trials. The company was founded by Bernhard Sabel, Anton Yurevich Fedorov and Kornelia Sabel in 2007 and is headquartered in Hennigsdorf, Germany. | Electronic Technology |
Biomodex SAS
![]() Biomodex SAS Commercial Printing/FormsCommercial Services Biomodex SAS develops 3D printed surgical simulators for medical education and patient-specific preoperative planning. It offers simulators for surgical procedures such as bone drilling, soft tissue suturing, medical device implantation, and sizing. The company was founded by Thomas Marchand and Sidarth Radjou on January 22, 2015 and is headquartered in Paris, France. | Commercial Services |
- Borsa valori
- Insiders
- Karl Schweitzer